Diabetes mellitus Samples
Central BioHub offers human serum samples from patients with Diabetes mellitus like Type 2 diabetes mellitus or Unspecified diabetes mellitus. You can use the filter functions to specify your desired products by laboratory parameters and donor specifications like ethnicity, BMI, medication, age and gender. Procurement takes place from consented donors under strict ethical standards. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.
545 Products
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Male Age: 43
- Diagnosed disease:
- E10.01 - Type 1 diabetes mellitus with ketoacidosis
- Medication:
- Kreon
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyroglobulin (Tg) Thyrotropin (TSH) Thyroxine (FT4) Triglycerides Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 43 Years
- BMI:
- 36 kg/m²
- Weight:
- 121 kg
- Height:
- 183 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
- Kreon
- Lantus
- Novorapid
- amlodipine
- atorvastatin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: < 0.60 U/mL
Source: this donation
|
< 0.90 U/mL
|
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: < 50.00 IU/mL
Source: this donation
|
< 100 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 39.90 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 77.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 0.80 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroglobulin (Tg) |
Qual: negative
Quant: 3.01 ng/mL
Source: this donation
|
2.00 - 70.00 ng/mL
|
Method: LIA (Luminescence Immuno Assay) System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.57 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 13.60 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triglycerides |
Qual: negative
Quant: 1.02 mmol/L
Source: this donation
|
< 2.25 mmol/L
|
Method: not specified System: not specified Beckman Coulter |
| Triiodothyronine (FT3) |
Qual:
Quant: 4.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH178719
1 mL (€37.50)
Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147121
1 mL (€37.50)
Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147118
1 mL (€37.50)
Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147115
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 63 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 63 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 56 kg/m²
- Weight:
- 152 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
- hypertension
- sleep apnoea
Medication:
- insulin
- metformin
Therapy:
- cardiac valve replacement
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH146089
1 mL (€37.50)
Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E11.90
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Humalog
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 70 kg
- Height:
- 164 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- E11.90
Medication:
- Humalog (active agent: insulin lispro)
- Lantus (active agent: insulin glargin)
- Metex (Dosages: 20mg/week)
- Orencia (Dosages: 750mg/4 weeks, active agent: abatacept)
- Prednisolon (Dosages: 1mg, as needed)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: positive
Quant: 33.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 4.71 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 6.10 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 35.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total IgM |
Qual: positive
Quant: 32.00 mg/dl
Source: this donation
|
40.00 - 230.00 mg/dl
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295179
1 mL (€37.50)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3
- Donor:
- Gender: Female Age: 33 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.01 - Type 1 diabetes mellitus with ketoacidosis
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 33 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 22 kg/m²
- Weight:
- 63 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
- L-thyroxine (Dosages: 100not specified)
- insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 319.40 kIU/L
Source: previous donation
|
< 34.00 kIU/L
|
Method: not specified System: Cobas Modular Roche |
| TSH Receptor Antibodies (TRAb) |
Qual: negative
Quant: 0.62 IU/L
Source: previous donation
|
< 1.22 IU/L
|
Method: not specified System: Cobas Modular Roche |
| Thyrotropin (TSH) |
Qual: positive
Quant: 23.37 mIU/L
Source: previous donation
|
0.27 - 4.20 mIU/L
|
Method: not specified System: not specified Roche |
| Thyrotropin (TSH) |
Qual: positive
Quant: 5.010 mU/L
Source: this donation
Remarks: sensitive |
0.270 - 4.200 mU/L
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 e-Module Roche |
| Thyroxine (FT4) |
Qual: negative
Quant: 12.70 pg/mL
Source: previous donation
|
9.30 - 17.00 pg/mL
|
Method: not specified System: not specified Roche |
| Triiodothyronine (FT3) |
Qual: negative
Quant: 2.60 pg/mL
Source: previous donation
|
2.00 - 4.40 pg/mL
|
Method: not specified System: not specified Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292329
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 72 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Nebivolol
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 72 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 80 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90]
- hyperlipoproteinaemia
- hypertension
Medication:
- Nebivolol
- amlodipine
- metfomin
- no incretin mimetics
- no insulin
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284062
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 79 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Bisoprolol
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 79 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 75 kg
- Height:
- 153 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90]
- gastritis
- hyperlipoproteinaemia
- hypertension
Medication:
- Bisoprolol
- Ramipril
- Xarelto
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284063
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Male Age: 68 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- DPP-4 inhibitor
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 68 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 98 kg
- Height:
- 180 cm
Sample:
- Matrix:
- Serum
- Condition:
- not specified
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
- thyroid disease
Medication:
- DPP-4 inhibitor
- blood thinner (because of stroke)
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 3.10 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH282850
1 mL (€37.50)
Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9
- Donor:
- Gender: Female Age: 74 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- incretin mimetics
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 74 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 68.8 kg
- Height:
- 155 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- hypothyroidism
Medication:
- incretin mimetics
- metformin
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Blood sugar (fasting) |
Qual:
Quant: 78.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165492
1 mL (€37.50)
Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 41 kg/m²
- Weight:
- 112 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- thyroid disease
Medication:
- L-thyroxine
- Toujeo (specific information from donor: Toujeo 300 U/ml)
- atorvastatin
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Blood sugar (fasting) |
Qual:
Quant: 135.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.60 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165497
1 mL (€37.50)
Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E06.3
- Donor:
- Gender: Male Age: 18 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.90
- Medication:
- Levemir
- Parameter:
- Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 18 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 83.5 kg
- Height:
- 173 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- E10.90
- vitamin D deficiency
Medication:
- Levemir
- Vigantoletten (specific information from donor: Vigantolette 500 IU)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual:
Quant: 230.90 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 149.60 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 2.98 mIU/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.80 pmol/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 6.85 pmol/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167019
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E78.2
- Donor:
- Gender: Female Age: 41 Ethnic group: Not specified
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Prednisolon
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 41 Years
- Ethnic group:
- Not specified
- BMI:
- 32 kg/m²
- Weight:
- 84 kg
- Height:
- 162 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Mixed hyperlipidaemia [E78.2]
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Prednisolon (specific information from donor: Prednisolon 5 mg)
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 173 mg/dl
Source: this donation
|
|
Method: not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.10 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165459
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- L-thyroxine
- Parameter:
- Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 18 kg/m²
- Weight:
- 52 kg
- Height:
- 160 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E11.90
- atrial fibrillation
Medication:
- L-thyroxine (specific information from donor: L-thyroxine 100)
- metformin
- no insulin
Therapy:
- surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis C Virus ribonucleic acid (HCV-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: qPCR (Real-Time Quantitative PCR) System: Cobas Ampliprep/Cobas TaqMan Roche |
| Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: PCR (Polymerase Chain Reaction) System: Cobas Ampliprep/Cobas TaqMan Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165346
1 mL (€75.00)
Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - E11.90
- Donor:
- Gender: Female Age: 72 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Dekristol
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Female
- Age:
- 72 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 67 kg
- Height:
- 150 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- E11.90
Medication:
- Dekristol (Dosages: 20000/week, acitve agent: vitamin D3)
- hydroxychloroquine (Dosages: 400/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.90 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 1.68 mg/L
Source: previous donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 75.00 mm/1h
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: positive
Quant: 62.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total IgM |
Qual: negative
Quant: 83.00 mg/dl
Source: this donation
|
40.00 - 230.00 mg/dl
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: positive
Quant: 54.00 IU/mL
Source: previous donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295181
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Male Age: 59 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- Novorapid
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 59 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 35 kg/m²
- Weight:
- 117 kg
- Height:
- 184 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
- Novorapid
- Toujeo
- Trulicity
- insulin
- metformin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.6 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283499
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 73 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Lantus
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 73 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 38 kg/m²
- Weight:
- 71.5 kg
- Height:
- 138 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Lantus
- Liprolog
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 149.00 mg/dl
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.20 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170850
1 mL (€37.50)
Human Serum - E11.9
- Donor:
- Gender: Male Age: 80 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Actrapid
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 80 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 98 kg
- Height:
- 187 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Actrapid
- Toujeo
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284126
1 mL (€37.50)
Human Serum - E11.21
- Donor:
- Gender: Female Age: 76 Ethnic group: Not specified
- Diagnosed disease:
- E11.21
- Medication:
- Januvia
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 76 Years
- Ethnic group:
- Not specified
- BMI:
- 27 kg/m²
- Weight:
- 68 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.21]
Medication:
- Januvia (specific information from donor: Januvia 50 mg)
- Losartan (specific information from donor: Losartan 100 mg)
- Prednisolon (specific information from donor: Prednisolon 1 mg)
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165523
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 60 Ethnic group: Not specified
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 60 Years
- Ethnic group:
- Not specified
- BMI:
- 30 kg/m²
- Weight:
- 79 kg
- Height:
- 162 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 107.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165575
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Male Age: 49 Ethnic group: Asian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 49 Years
- Ethnic group:
- Asian
- BMI:
- 26 kg/m²
- Weight:
- 99 kg
- Height:
- 196 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- L-thyroxine
- Victoza
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.20 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165485
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Female Age: 54 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- no incretin mimetics
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 54 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 78 kg
- Height:
- 164 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- dietary change diet (information given at the time of donation)
Diseases:
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
- no incretin mimetics
- no insulin
Therapy:
- gastric bypass
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.90 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH198043
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Female Age: 57 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Irbesartan
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Female
- Age:
- 57 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 85 kg
- Height:
- 163 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hashimotos thyroiditis
- Mnires disease
- diabetes mellitus [E11.9] - type 2 (not specified)
- hyperlipidaemia
- hypertension
Medication:
- Irbesartan
- L-thyroxine (Dosages: 125not specified)
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.50 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170899
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - D35.2
- Donor:
- Gender: Male Age: 59 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 59 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 103 kg
- Height:
- 180 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Benign neoplasm of pituitary gland [D35.2]
- I10.90
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
- hypertension
- pituitary adenoma
Medication:
- insulin
- metformin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283998
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.
- Donor:
- Gender: Female Age: 70 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11. - type 2 (not specified)
- Medication:
- Insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 70 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 79 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.] - type 2 (not specified)
- fibromyalgia
- hepatic cirrhosis - early stadium (not specified)
- hepatic fibrosis
- hypertension
- spinal stenosis
Medication:
- Insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.10 %
Source:
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH169862
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E78.2
- Donor:
- Gender: Male Age: 58 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 58 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 94 kg
- Height:
- 190 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Mixed hyperlipidaemia [E78.2]
- bronchial asthma
- diabetes mellitus [E11.90] - type 2 (not specified)
- postthrombotic syndrome
- renal insufficiency - grade III (not specified)
Medication:
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.90 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165472
1 mL (€37.50)
Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK) - E06.3
- Donor:
- Gender: Male Age: 32 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.91 - type 1 (reliable diagnosis)
- Medication:
- Lantus
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Thyroid peroxidase (aTPO / MAK)
Donor:
- Gender:
- Male
- Age:
- 32 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 71 kg
- Height:
- 188 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- slightly lipemic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- diabetes mellitus [E10.91] - type 1 (reliable diagnosis)
Medication:
- Lantus (active agent: insulin glargin)
- Novorapid (active agent: insulin aspart)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: 0.90 U/mL
Source: this donation
|
< 1.00 U/mL
Remarks: borderline 1,00 - 1,90, positive >= 2,00 |
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 345.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294615
1 mL (€37.50)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK) - E06.3
- Donor:
- Gender: Male Age: 32 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.91 - type 1 (reliable diagnosis)
- Medication:
- Lantus
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Thyroid peroxidase (aTPO / MAK)
Donor:
- Gender:
- Male
- Age:
- 32 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 71 kg
- Height:
- 188 cm
Sample:
- Matrix:
- Serum
- Condition:
- slightly lipemic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- diabetes mellitus [E10.91] - type 1 (reliable diagnosis)
Medication:
- Lantus (active agent: insulin glargin)
- Novorapid (active agent: insulin aspart)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: 0.90 U/mL
Source: this donation
|
< 1.00 U/mL
Remarks: borderline 1,00 - 1,90, positive >= 2,00 |
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 345.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294613
1 mL (€37.50)
Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK) - E06.3
- Donor:
- Gender: Male Age: 32 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.91 - type 1 (reliable diagnosis)
- Medication:
- Lantus
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Thyroid peroxidase (aTPO / MAK)
Donor:
- Gender:
- Male
- Age:
- 32 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 20 kg/m²
- Weight:
- 71 kg
- Height:
- 188 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- slightly lipemic
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- diabetes mellitus [E10.91] - type 1 (reliable diagnosis)
Medication:
- Lantus (active agent: insulin glargin)
- Novorapid (active agent: insulin aspart)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual: negative
Quant: 0.90 U/mL
Source: this donation
|
< 1.00 U/mL
Remarks: borderline 1,00 - 1,90, positive >= 2,00 |
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual: positive
Quant: 345.00 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH294614
1 mL (€37.50)
